M&A Healthcare Advisors: What We Learned in 2022 and What to Expect in 2023
Mark Thomas, Mike Moran and Andre Ulloa recently sat down to discuss their thoughts on their 2022 takeaways and 2023 predictions. The three are co-founders of M&A Healthcare Advisors, a boutique mergers and acquisition firm serving mid-market healthcare companies.
They report that transactions were strong in 2022 and similar to those of 2021, despite some predictions of diminishing activity and valuations. The trio predicts that this trend will continue in 2023.
Additionally, the co-founders noted an increasing trend of strategic buyers in the market, looking to acquire businesses for the purpose of gaining personnel and creating synergies. They anticipate that this trend will continue, particularly as the broader economy starts to decline.
Follow us on social media for the latest updates in B2B!